"Sometimes it feels as if we’re seeing the biosimilars version of ‘Groundhog Day,’" FDA Commissioner says of the tactics used to fend of competition to biologics.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
